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DJ-1 protects against cell death following acute
cardiac ischemia–reperfusion injury
RK Dongworth1,5, UA Mukherjee1,5, AR Hall1, R Astin2, S-B Ong1,3, Z Yao2, A Dyson4, G Szabadkai2, SM Davidson1, DM Yellon1
and DJ Hausenloy*,1
Novel therapeutic targets are required to protect the heart against cell death from acute ischemia–reperfusion injury (IRI).
Mutations in the DJ-1 (PARK7) gene in dopaminergic neurons induce mitochondrial dysfunction and a genetic form of
Parkinson’s disease. Genetic ablation of DJ-1 renders the brain more susceptible to cell death following ischemia–reperfusion in
a model of stroke. Although DJ-1 is present in the heart, its role there is currently unclear. We sought to investigate whether
mitochondrial DJ-1 may protect the heart against cell death from acute IRI by preventing mitochondrial dysfunction.
Overexpression of DJ-1 in HL-1 cardiac cells conferred the following beneficial effects: reduced cell death following simulated IRI
(30.4±4.7% with DJ-1 versus 52.9±4.7% in control; n¼ 5, Po0.05); delayed mitochondrial permeability transition pore (MPTP)
opening (a critical mediator of cell death) (260±33 s with DJ-1 versus 121±12 s in control; n¼ 6, Po0.05); and induction of
mitochondrial elongation (81.3±2.5% with DJ-1 versus 62.0±2.8% in control; n¼ 6 cells, Po0.05). These beneficial effects of
DJ-1 were absent in cells expressing the non-functional DJ-1L166P and DJ-1Cys106A mutants. Adult mice devoid of DJ-1 (KO) were
found to be more susceptible to cell death from in vivo IRI with larger myocardial infarct sizes (50.9±3.5% DJ-1 KO versus
41.1±2.5% in DJ-1 WT; nZ7, Po0.05) and resistant to cardioprotection by ischemic preconditioning. DJ-1 KO hearts showed
increased mitochondrial fragmentation on electron microscopy, although there were no differences in calcium-induced MPTP
opening, mitochondrial respiratory function or myocardial ATP levels. We demonstrate that loss of DJ-1 protects the heart from
acute IRI cell death by preventing mitochondrial dysfunction. We propose that DJ-1 may represent a novel therapeutic target for
cardioprotection.
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Novel therapeutic strategies capable of protecting the heart
against acute ischemia–reperfusion injury (IRI) are needed to
reduce myocardial infarct (MI) size, preserve left ventricular
(LV) systolic function and improve clinical outcomes in
patients with ischemic heart disease (IHD), the leading cause
of death and disability worldwide. Mitochondrial dysfunction
induced by acute IRI is a major determinant of myocardial
injury and cardiomyocyte cell death. Preservation of cardio-
myocyte mitochondrial function in patients following IRI may
therefore be expected to reduce cell death, prevent the onset
of heart failure and ultimately improve long-term prognosis of
IHD patients.
DJ-1 (also known as PARK7 (Parkinson disease
(autosomal recessive, early onset) 7)) is a widely expressed
and conserved mitochondrial protein that has been
implicated in numerous pathologies, most notably in
neurodegeneration where mutations in DJ-1 (e.g., the
L166P mutation) ultimately result in an early-onset familial
form of Parkinson’s disease.1 Several experimental studies
have elucidated important properties for DJ-1, including
oxidative stress sensing, reactive oxygen species
scavenging2–4 and preservation of normal mitochondrial
function in the brain.2,5,6 Given its crucial role in maintaining
mitochondrial function, DJ-1 represents a potential target for
novel therapies for other pathologies involving mitochondrial
dysfunction and cell death, including IRI. Indeed, animal
studies have shown that DJ-1 ablation renders the brain more
susceptible to cell death in the setting of stroke.7 Although
DJ-1 is expressed in the heart,1 its role there is not well
understood.
In the current study, we investigated the role of mitochon-
drial DJ-1 in the heart and its potential as a novel therapeutic
target for protecting the heart against cell death following
acute IRI.
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Results
DJ-1 overexpression reduced HL-1 cell death from
simulated IRI. Cell death was assessed in the HL-1 cardiac
cell line in response to simulated IRI. WT DJ-1 over-
expressing cells exhibited significantly lower cell death
following simulated IRI (Figure 1a: cell death: WT DJ-1
30.4± 4.7% versus vector control 52.9±4.7%, n¼ 5,
*Po0.05) to a similar extent as the insulin-positive control.
Expression of mitochondrial targeted DJ-1 (MitoDJ-1) also
reduced cell death, although this was not statistically
significant (Figure 1a: cell death: MitoDJ-1 38.5±3.5%
versus vector control 52.9±4.7%, n¼ 5, NSP40.05 (NS,
not statistically significant)). Interestingly, expression of
mutant DJ-1 did not affect cell death following simulated IRI
(Figure 1a: cell death: L166P 55.1±3.2%, Cys106A
62.8±7.3% versus vector control 52.9±4.7%; n¼ 5,
NSP40.05). Cell death in un-transfected time-matched
normoxic control cells was o5.0%, and this was not
significantly altered by transgene expression (data not
shown).
DJ-1 overexpression delayed mitochondrial permeability
transition pore (MPTP) opening in HL-1 cells. MPTP
opening is a critical mediator of cell death. DJ-1 over-
expression significantly delayed MPTP opening in HL-1 cells
(Figure 1b: normalized half-times: WT DJ-1 260±33 s versus
vector control 121±12 s, n¼ 6, *Po0.05). Expression of
MitoDJ-1 also significantly delayed MPTP opening (Figure 1b:
normalized half-times: MitoDJ-1 290±42 s versus vector
control 121±12 s, nZ5, **Po0.01). Expression of DJ-1
mutants, L166P and Cys106A did not significantly affect
MPTP opening times in this model (Figure 1b: normalized half-
times: L166P 211±25 s, Cys106A 190±33 s versus vector
control 121±12 s, n¼ 6, NSP40.05).
DJ-1 overexpression induced mitochondrial elongation
in HL-1 cells. Mitochondrial morphology is an important
indicator of cellular health and susceptibility to cell death;
where mitochondrial elongation confers a cardioprotective
phenotype. DJ-1 overexpression increased the proportion of
cells displaying predominantly elongated mitochondria
(Figure 1d: cells with elongated mitochondria: WT DJ-1
81.3±2.5% versus vector control 62.0± 2.8%; n¼ 6,
*Po0.05). Expression of MitoDJ-1 also induced significant
mitochondrial elongation (Figure 1d: cells with elongated
mitochondria: MitoDJ-1 83.2±7.1% versus vector control
62.0± 2.8%; nZ5, *Po0.05). Expression of DJ-1 mutants
did not significantly affect mitochondrial morphology
(Figure 1d: cells with elongated mitochondria: L166P
67.9±5.7%, Cys106A 56.4±4.5% versus vector control
62.0± 2.8%; n¼ 6, NSP40.05).
Cardiac phenotype in DJ-1 WT and knockout (KO)
mice. There were no significant differences in anterior and
posterior LV wall dimensions during systole or diastole
(examples of echocardiographic images are provided in
Supplementary Figure S1). Isoproterenol stress yielded a
significant increase in heart rate in both DJ-1 WT and KO
Figure 1 Assessment of the role of DJ-1 in vitro. Modulation of DJ-1 protein in vitro in HL-1 cells by transfection with WT and MitoDJ-1 and non-functional mutant DJ-1
(L166P and Cys106A). (a) Cell survival in response to simulated IRI, n¼ 5/group. (b) MPTP opening in response to laser-induced oxidative stress, nZ5/group.
(c) Representative images of TMRM-loaded mitochondria: (i) Control, (ii) WT-DJ (more elongated mitochondria), (iii) Cys106A and (iv) MitoDJ-1 (more elongated
mitochondria). (d) Mitochondrial morphology, nZ5/group. Significance assessed by one-way ANOVA; significance indicated against comparison with control (white bars).
*Po0.05, **Po0.01
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animals (Figure 2a: heart rate in beats per minute: WT DJ-1
baseline 498.5±19.9 and isoproterenol 620.2±10.2, n¼ 6,
Po0.05; DJ-1 KO baseline 505±25.9 and isoproterenol
628.8±17.0, n¼ 5, Po0.05) and fractional shortening
(Figure 2b: percentage of fractional shortening: WT DJ-1
baseline 34.7±3.1 and isoproterenol 63.0±1.2, n¼ 6,
Po0.05; DJ-1 KO baseline 41.2±4.1 and isoproterenol
65.4±3.2, n¼ 5, Po0.05). There were no differences in
cardiac output or stroke volume between DJ-1 WT and KO
mice at baseline or following isoproterenol challenge (Figures
2c and d).
DJ-1 KO increased susceptibility to cell death from IRI
in vivo. DJ-1 KO mice exhibited a significant increase in
cardiomyocyte cell death following in vivo IRI compared with
DJ-1 WT ones (Figure 3a: infarct size %IS/AAR (infarct size/
area-at-risk): DJ-1 KO 50.9±3.5% versus DJ-1 WT
41.1±2.5; nZ7/group, *Po0.05). Interestingly, DJ-1 KO mice
appeared to be partially resistant to the MI size limiting effects
of ischemic preconditioning (IPC) (Figures 3b and c:
%IS/AAR in DJ-1 KO mice: control 50.9±3.5% versus IPC
39.4±4.1%, n¼ 8/group, NSP40.05). The extent of cardio-
protection afforded by IPC wasE47% in WTs compared with
only E23% in KOs. There were no significant differences
in body weight, heart weight or area-at-risk between any
treatment groups in these experiments.
Calcium-induced MPTP opening in DJ-1 WT and DJ-1 KO
mice. It was not possible to examine MPTP opening in
primary isolated cardiomyocytes, as there was a strong trend
to decreased mitochondrial membrane potential in DJ-1 KO
hearts (Supplementary Figure S2), thereby precluding the
Figure 2 Echocardiographic phenotyping of DJ-1 WT and KO animals. (a–d) Isoproterenol (4 ng/g) treatment significantly increased the heart rate and fractional
shortening in both DJ-1 WT and KO mice (nZ5/group; significance assessed by one-way ANOVA comparing WT Basal with WT ISO and KO Basal with KO ISO, where
**Po0.01 and ***Po0.001). There were no significant differences in any cardiac parameter between DJ-1 WT and KO mice at baseline or in response to isoproterenol
challenge (nZ5/group, significance assessed by one-way ANOVA comparing WT and KO, NSP40.05)
Figure 3 Susceptibility of DJ-1 KO to in vivo IRI. Infarct size following in vivo IRI in DJ-1 WT and KO mice. IS normalized to myocardial AAR to give IS/AAR%. (a) IS/AAR%
in DJ-1 WT and KO mice subjected to standard IRI model of 45 min ischemia and 24 h reperfusion, nZ7/group. (b and c) IS/AAR% where standard IPC protocol of 5 min
ischemia and 5 min reperfusion applied before main ischemic insult, nZ7/group. Significance assessed by unpaired t-test, *Po0.05, ***Po0.001. No statistical significance
indicated as NSP40.05
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use of the tetramethyl rhodamine methyl ester (TMRM)-
based MPTP opening model. There were no differences in
the swelling of mitochondria isolated from DJ-1 WT or DJ-1
KO hearts, suggesting that there was no difference in MPTP
opening susceptibility (Figures 4a–c). As expected, ciclos-
porin A (CsA) treatment prevented calcium-induced mito-
chondrial swelling in both DJ-1 WT and DJ-1 KO
mitochondria (Figure 4d).
DJ-1 KO hearts display increased mitochondrial
fragmentation. At baseline, DJ-1 KO hearts exhibited a
significantly greater proportion of short mitochondria (o1
sarcomere in length) and a concurrent decrease in longer
mitochondria (Z1 sarcomere in length) (Figures 5a and b,
nZ3/group). Sublethal ischemia resulted in increased
proportions of short mitochondria in both DJ-1 WT and KO
hearts. Interestingly, following ischemia, there was no
significant difference in mitochondrial length between DJ-1
WT and DJ-1 KO hearts (see Supplementary Figure S3).
Myocardial adenosine triphosphate (ATP) levels in DJ-1
WT and DJ-1 KO mice. There were no significant differ-
ences in myocardial ATP levels between DJ-1 WT and DJ-1
KO mice at baseline (Figure 6a, nZ5/group, NSP40.05).
Figure 4 Calcium-induced mitochondrial swelling in isolated mitochondria. Mitochondria isolated from DJ-1 WT and KO hearts were subjected to calcium-induced
mitochondrial swelling. Extent of mitochondrial swelling was assessed by optical density using spectrophotometer. (a) Baseline. (b) Calcium chloride (CaCl2) 600mM.
(c) CaCl2 800 mM. (d) CsA pre-treatment at 1mM for 15 min before swelling assay using 600mM CaCl2. No apparent differences in mitochondrial swelling between DJ-1 WT
and KO mitochondria, n¼ 6/group
Figure 5 Mitochondrial morphology in DJ-1 WT and KO hearts at baseline. Mitochondrial morphology in DJ-1 WT and KO hearts was assessed using EM of hearts isolated
at baseline. (a) Representative EM images showing mitochondrial morphology in DJ-1 WT (i) and KO (ii) hearts at baseline; scale bar¼ 2mM. (b) Assessment of mitochondrial
morphology by quantification of the proportion of mitochondriao1 sarcomere in length, equivalent to 1 sarcomere in length and 41 sarcomere in length, nZ3/group.
Significance assessed by one-way ANOVA; significance indicated against comparison with DJ-1 WT control (white bars), *Po0.05, **Po0.01, ***Po0.001
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Mitochondrial respiration in DJ-1 WT and DJ-1 KO
mice. There were no differences in mitochondrial respiratory
rates between the DJ-1 WT and DJ-1 KO hearts at baseline
(Figure 6b, nZ5/group, NSP40.05).
The effect of DJ-1 genetic ablation on myocardial ATP
levels and mitochondrial respiration could not be examined
effectively in these animals, as a sublethal ischemic insult (of
20 min ischemia) did not induce a significant effect (see
Supplementary Figure S4). The effect of an extended
ischemic insult was not feasible given the clear effect of
DJ-1 genetic ablation on cell survival indicated here.
Discussion
In the present study, we demonstrate that mitochondrial DJ-1
may be an important therapeutic target for cardioprotection as
evidenced by the following:(1) overexpression of WT DJ-1 but
not its mutant forms reduced cell death following simulated
IRI, delayed MPTP opening, and induced mitochondrial
elongation in the HL-1 cardiac cell line; and (2) adult murine
hearts deficient in DJ-1 were found to be more susceptible to
cell death from IRI as evidenced by a larger MI size, a finding
which was associated with increased mitochondrial
fragmentation.
The beneficial effects of WT DJ-1 overexpression in HL-1
cells observed in our study appeared to be dependent on the
ability of DJ-1 to dimerize and sense oxidation, as these
effects were absent with the mutant forms of the protein,
DJ-1L166P (which is unable to dimerize) and DJ-1Cys106A
(in which Cys106 is resistant to oxidation). Dimerization and
oxidation of DJ-1 are both known to be critical steps in its
activation and mitochondrial translocation.8,9 The beneficial
effects of DJ-1 overexpression included reduced cell death
from simulated IRI and protective effects on mitochondrial
function, including delayed onset of MPTP opening (a critical
mediator of cell death)10 and mitochondrial elongation
(a change in mitochondrial morphology which has been
reported to confer a cardioprotective phenotype).11 Although
it should be noted that the cell death assay performed here
could be improved by use of a more quantitative end point
such as flow cytometry, the protective effect of DJ-1 over-
expression against simulated IRI is also confirmed by the
recent demonstration of a similar effect in H9c2 rat
myoblasts.12
Adult mice deficient in DJ-1 were found to display no overt
cardiac phenotype in terms of cardiac dimensions and
function. This would suggest that DJ-1 does not appear to
have a critical role in cardiac function under physiological
conditions. The lack of any obvious cardiac phenotype such
as LV hypertrophy therefore allowed us to examine the effect
of DJ-1 deficiency on susceptibility to IRI, without any
confounding myocardial pathology. Crucially, we found that
hearts deficient in DJ-1 were more susceptible to cell death
from acute IRI, as evidenced by a larger MI size. This finding
suggests that endogenous DJ-1 may be an important target
for cardioprotection. Interestingly, we also found that adult
hearts lacking DJ-1 were resistant to the endogenous
cardioprotective phenomenon of IPC, suggesting that DJ-1
may contribute to the signaling pathway underlying IPC. DJ-1
has also been reported to act as a mediator of hypoxic
preconditioning in H9c2 rat myoblasts.13 In the brain, it has
been reported that DJ-1 can increase the activity of the pro-
survival kinase, Akt.13–15 Whether DJ-1 is required for the
activation of Akt in the setting of IPC is an interesting
possibility that remains to be explored.
Because DJ-1 overexpression in the HL-1 cell line delayed
the onset of MPTP opening, we were expecting to observe an
increased susceptibility to MPTP opening in cardiac mito-
chondria isolated from DJ-1 KO mice, but this was not the
case. The reason for this discrepancy may relate to the
experimental model used to induce and assess MPTP
opening. In the HL-1 cell studies, MPTP opening was induced
by oxidative stress in intact cardiomyocytes, whereas in the
DJ-1 KO mice, MPTP opening was induced by calcium using
isolated mitochondria. It was not possible to use the oxidative
stress TMRM model of MPTP opening in cardiomyocytes
isolated from DJ-1 KO hearts given the prominent trend to
decreased mitochondrial membrane potential at baseline in
DJ-1 KO cardiomyocytes compared with wild-type (WT)
controls (Supplementary Figure S2). Many of the beneficial
effects of DJ-1 in the brain relate to its anti-oxidant properties,
and its ability to translocate to the mitochondria, and this may
in part explain why we did not see the expected effects of DJ-1
ablation on MPTP opening in the isolated mitochondria model
Figure 6 Functional characterization of DJ-1 WT and KO hearts. (a) Myocardial ATP assay in DJ-1 WT and KO hearts. ATP assessed using luminescence assay and
normalized to DJ-1 WT baseline, nZ5/group. No significant difference in ATP levels between DJ-1 WT and KOs; significance assessed by unpaired t-test, NSP40.05.
(b) Mitochondrial respiration assessed by oxygen flux readings for individual respiratory complexes in mitochondria isolated from DJ-1 WT and KO hearts, nZ5/group. No
significant difference in mitochondrial respiratory function; significance assessed by one-way ANOVA, significance indicated against comparison with DJ-1 WT control (white
bars), NSP40.05. Characterization of ATP levels and mitochondrial respiration in DJ-1 WT hearts is shown in Supplementary Figure S4
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of calcium-induced MPTP opening. Indeed, it has recently
been shown that DJ-1 protects the heart from oxidative stress
resulting from transaortic banding.16
The overexpression of DJ-1 in HL-1 cardiac cells resulted in
an increase in the proportion of cells displaying predominantly
elongated mitochondria, a phenotype which we have pre-
viously reported to prevent IRI-induced mitochondrial fission
and to be associated with cell survival.11 Interestingly, in the
DJ-1 KO murine hearts we observed increased mitochondrial
fragmentation. These findings suggest that mitochondrial
DJ-1 can modify mitochondrial morphology, although the
mechanism through which this is achieved is unclear. The
protective effect of DJ-1 against mitochondrial fragmentation
has also been reported in cultured SH-SY5Y cells.17 Despite
the changes in mitochondrial morphology in DJ-1 KO hearts,
we did not find any difference in mitochondrial respiration
rates or myocardial ATP levels, suggesting that DJ-1 is not
crucial for mitochondrial function at basal conditions. Whether
we would have observed mitochondrial dysfunction under
conditions of IRI remains to be determined. Interestingly,
experimental studies of DJ-1 in the brain have also demon-
strated that the DJ-1 ablation did not affect mitochondrial
respiration in mouse embryonic fibroblast cells or primary
isolated mitochondria from the cerebral cortex.18 It must be
appreciated that DJ-1 may protect against cell death through
other mechanisms, including (1) an anti-apoptotic pathway in
which it sequesters death-domain-associated protein (Daxx)
to disrupt Daxx-ASK1 (apoptosis signal-regulating kinase 1)
regulated apoptosis19 or (2) mitophagy.6
In summary, we have found that in the adult murine heart
DJ-1 may be a novel target for protecting the myocardium
against cell death from acute IRI. Experimental studies have
shown that the upregulation of DJ-1 by sodium 4-phenylbu-
tyrate protected against acute IRI in the brain.20,21 Whether
this therapeutic approach is effective against acute myocar-
dial IRI remains to be investigated.
Materials and Methods
All animal experiments were conducted in accordance with the Animals (Scientific
Procedures) Act 1986 published by the UK Home Office and the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes of Health
1996. All laboratory reagents were purchased from Sigma (Poole, UK) unless
otherwise stated.
HL-1 cell plasmid transfection. All in vitro experiments were conducted
using the HL-1 cardiac cell line, cultured as described in published methods.22
HL-1 cells were transfected using Fugene6 (Roche, Basel, Switzerland)
according to the manufacturer’s instructions. Plasmids were: empty plasmid
vector (RcCMV), mitochondrial red fluorescent protein (MtRFP), mitofusin 1
(Mfn1; Pcb6-MYC-Mfn1) (Professor L Scorrano, University of Padova, Padova,
Italy), WT DJ-1 (WT DJ-1) (Dr. Z Yao and Dr. G Szabadkai, University College
London, London, UK), WT DJ-1 with FLAG-tag sequence (pRK5 Flag DJ-1 WT)
(Dr. Z Yao and Dr. G Szabadkai, University College London, London, UK),
MitoDJ-1 (Dr. Z Yao and Dr. G Szabadkai, University College London, London,
UK), L166P mutant DJ-1 (Dr. Z Yao and Dr. G Szabadkai, University College
London, London, UK), Cys106A mutant DJ-1 (Professor P Kahle, University
Clinics Tu¨bingen, Tu¨bingen, Germany), and plasmid-enhanced green fluorescent
protein (Clontech, Mountain View, CA, USA). All cell experiments were
conducted 24 h post transfection.
Cell death following simulated IRI in vitro. HL-1 cells were subjected
to simulated IRI comprising simulated ischemia for 12 h in ischemic buffer in an
air-tight hypoxic chamber and simulated reperfusion for 1 h in normoxic buffer on
removal from the hypoxic chamber. Cell death was assessed in 50 cells by
propidium iodide staining, and PeGFP expression was observed using
fluorescence microscopy (Nikon Eclipse TE200, Nikon, Kingston Upon Thames,
UK). Control cell death was determined in un-transfected HL-1 cells incubated in
oxygenated normoxic buffer for 13 h. Insulin (Invitrogen, Paisley, UK) treatment
(275 U/ml) administered at the onset of reperfusion was used as a positive control.
MPTP opening in vitro. MPTP opening in HL-1 cells was induced using
laser-induced mitochondrial oxidative stress as previously published.11,23 HL-1
cells were loaded with 3 mM TMRM for 15 min at 37 1C and imaged by time-scan
confocal microscopy (Leica, Wetzlar, Germany). Time to MPTP opening was
measured as the time taken to reach half maximum cytosolic TMRM fluorescence
intensity of 15 cells for a minimum of five experiments. Sanglifehrin A (1 mM), a
known MPTP inhibitor, was used as a positive control.
Mitochondrial morphology in vitro using confocal microscopy.
HL-1 cell mitochondrial morphology was assessed using confocal microscopy
(Leica) and MtRFP, as previously published.11 Ten randomly selected cells for a
minimum of five independent experiments were imaged using a  63 1/35
numerical aperture oil objective. Mitochondrial morphology was assessed by three
blinded analyzers and defined as predominantly (450%) elongated or
fragmented. Mfn1 was used as a positive control.
DJ-1 whole-body KO mice. Mice with whole-body genetic ablation of the
DJ-1 gene (B6.Cg-Park7tm1Shn/J) were originally created by Goldberg et al,24
backcrossed onto C57BL/6 background for at least 12 generations. DJ-1 KO mice
were always compared against true WT littermate controls (DJ-1 WT).
Echocardiographic phenotyping. Cardiac phenotyping of DJ-1 WT and
DJ-1 KO animals was performed by transthoracic two-dimensional echocardio-
graphy with Vivid 7 Dimension and 14 MHz probe (GE Healthcare, Hatfield, UK) as
previously published25 to determine LV dimensions, heart rate, cardiac output,
stroke volume and fractional shortening. Phenotyping was performed at baseline
and 4 min following isoproterenol challenge (4 ng/g (Sigma) intraperitoneal bolus).
Myocardial ischemia–reperfusion in vivo. DJ-1 WT and DJ-1 KO
animals underwent in vivo myocardial IRI comprising open-chest surgery for
occlusion of left anterior descending coronary artery followed by reperfusion. Non-
recovery: Anesthesia was provided by ketamine 10 mg/ml (Vetalar, Boehringer
Ingelheim, Bracknell, UK), xylazine 2 mg/ml (Rompun, Bayer, Newbury, UK) and
atropine 0.06 mg/ml (Sigma) at 0.1 ml/10 g and 0.1 ml doses thereafter as
required. Recovery: Anesthesia was by inhaled isoflurane (1.5–2.0% vaporized in
1.5 l/min oxygen). Analgesia was provided by buprenorphine (Vetergesic, Alstoe
Animal Health, York, UK) 0.1 mg/kg intramuscular at 0, 6 and 24 h post surgery.
Standard recovery IRI experiments comprised 15-min stabilization, 45-min
ischemia and 24-h reperfusion. IPC protocol was 5-min stabilization, 5-min
ischemia and 5-min reperfusion before the index ischemic event.
MI size following in vivo IRI. At 24 h reperfusion, mice were anesthetized
using non-recovery anesthetics as above, and hearts were rapidly extracted for
staining with triphenyl-tetrazolium chloride and Evan’s blue for determining MI size
and AAR, respectively. Quantifications were performed on transverse heart slices
using ImageJ planimetry (NIH Image, Bethesda, MD, USA), and MI size was
expressed as percentage of AAR (%IS/AAR).
Calcium-induced MPTP assay. Mitochondrial swelling was examined in
mitochondria isolated from DJ-1 WT and DJ-1 KO hearts. Mitochondria were
isolated by Trypsin (5 mg/ml) according to a modified protocol.26 Mitochondria
were purified by differential centrifugation, and calcium-triggered mitochondrial-
swelling assays were performed as described by Hafner et al.27 Briefly, calcium
chloride (600 or 800 mM) was added to mitochondria, and optical density was
measured by spectrophotometry (FLUOstar Omega, BMG Labtech, Cary, NC,
USA) for 17 min. Treatment with the known MPTP inhibitor, CsA (1.0mM), was
used as a positive control.
Mitochondrial morphology by electron microscopy (EM). DJ-1
WT and DJ-1 KO hearts at baseline or after 20-min ischemia (nZ3/group) were
prepared for EM as previously published and imaged using a Jeol 1010 electron
microscope (Jeol Ltd, Welwyn Garden City, UK).11 Ten images were taken for
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each heart. Mitochondrial elongation was assessed by comparison of interfibrillar
mitochondria (IFM) to sarcomere length. Analysis was performed by two blinded
analyzers on a total of 500–600 IFM.
Myocardial ATP assay. The left ventricles from DJ-1 WT and DJ-1 KO
hearts were homogenized in PBS containing protease and phosphatase inhibitors
and EDTA (pH 8.0) (Thermo Scientific, Epsom, UK) 1 ml/0.1 g of tissue.
Myocardial ATP levels were measured using ATP bioluminescence assay kit
(Sigma) in accordance with the manufacturer’s instructions where luminescence
was read every 5 s for 2 min (FLUOstar Omega, BMG Labtech).
Mitochondrial respiration assay. Mitochondria were isolated from DJ-1
WT and DJ-1 KO hearts as described above. Oxygen consumption rates were
measured using a high-resolution respirometer equipped with a Clark oxygen
sensor (Oroboros Oxygraph, Paar KG, Graz, Austria).
Statistics. All values are expressed as mean±S.E.M. Data were analyzed by
one-way analysis of variance (ANOVA) and Tukey’s multiple-comparison post-hoc
test or unpaired t-test where indicated. Differences were considered significant
when *Po0.05.
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